Skip to content

Inventories at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$27.9M-1.4%
Labcorp Holdings logo
Labcorp HoldingsLH
-$65.1M-113%
Opko Health logo
Opko HealthOPK
$61.85M-6.8%
NeoGenomics logo
NeoGenomicsNEO
$27.14M-20.6%
Natera, Inc. logo
Natera, Inc.NTRA
$70.72M+40.4%
Agilent Technologies logo
Agilent TechnologiesA
$1.09B+9.9%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.04B+38.7%
Enterprise value$31.8B+28.0%
P/E24.5×+4.8×
P/S2.3×+0.5×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Quest Diagnostics’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's inventories?
Quest Diagnostics (DGX) reported inventories of $233M in Q2 2026.
How has Quest Diagnostics's inventories changed year-over-year?
Quest Diagnostics's inventories increased by 24.6% year-over-year, from $187M to $233M.
What is the long-term trend for Quest Diagnostics's inventories?
Over 5 years (2020 to 2025), Quest Diagnostics's inventories has grown at a -3.3% compound annual growth rate (CAGR), from $223M to $189M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.